If you started a GLP-1 a year ago with a BMI of 38 and you are now down to 33, your prescriber attests to the higher number and you still qualify
These medications should be avoided during pregnancy, breastfeeding, or when planning pregnancy (stop in advance according to product guidance)
Potential for age-related GH deficiency GH secretion progressively declines with age (somatopause), contributing to sarcopenia, increased adiposity, and decreased bone density
Semaglutide provides comprehensive health benefits beyond just weight loss, reducing risks for serious conditions such as heart disease and diabetes, making it a holistic approach to enhanced long-term health
This dual-action mechanism is what makes tirzepatide more effective at all the things semaglutide does, including: Slowing down digestion Regulating your appetite Controlling blood sugar by increasing insulin production and inhibiting glucagon Its dual-action approach is also most likely the reason tirzepatide can provide even greater weight loss and blood sugar control than medications that target only GLP-1, such as semaglutide